Projecting changes in demographics and causes of death people with HIV in western Europe from 2025 to 2050 a mathematical modelling study
Por:
Ambia, J, van Sighem, A, Pantazis, N, Gill, MJ, Grabar, S, Monforte, AD, Zangerle, R, Bruguera, A, Teira, R, Jarrin, I, Vehreschild, J, Cavassini, M, van der Valk, M, Bonnet, F, Sterne, JAC, Ingle, SM and Trickey, A
Publicada:
1 dic 2025
Ahead of Print:
1 nov 2025
Resumen:
Background Antiretroviral therapy (ART) scale-up in western Europe has reduced the incidence of AIDS-related conditions, increased life expectancies, and led to an ageing population of people with HIV. We aimed to project cause-specific mortality patterns in western Europe by 2050 in the context of changes in demographics and ART use. Methods We used a deterministic compartmental model calibrated in a Bayesian framework. From 2010 to 2023, the model was parameterised and calibrated using epidemiological data from the European Centre for Disease Prevention and Control, UNAIDS, and the Antiretroviral Therapy Cohort Collaboration, including information on rates of cause specific mortality by demographics and CD4 cell counts. The number of deaths and mortality rates were modelled for a status quo scenario (where ART coverage and HIV incidence remained stable) from 2025 to 2050, as well as different scenarios in which various changes to ART coverage and HIV incidence were assumed. Findings By 2050, 839 761 (95% credible interval 789 451-860 875) people with HIV are projected to be living western Europe, with 90% taking ART. The percentage of people with HIV older than 75 years is projected to increase from 8% in 2025 to 24% in 2050. The all-cause mortality rate is estimated to increase from 131 (125-136) per 100 person-years in 2025 to 204 (195-212) in 2050. Between 2010 and 2025, there was an estimated decline AIDS-related deaths of 442% (377-501). From 2025 to 2050, projected AIDS-related mortality rates are estimated to remain constant at 021 per 100 person-years under a status quo scenario. Cardiovascular-related mortality rates are estimated to increase from 024 per 100 person-years (022-025) in 2025 to 050 (040-053) in 2050 and non AIDS-defining cancers to increase from 031 per 100 person-years (030-032) in 2025 to 053 (050-056) in 2050, becoming the two leading causes of death by 2050 in people with HIV. Over the next 25 years, if there is an increase in ART coverage (reaching 94% in 2030) and a steady decrease in HIV incidence, there are projected to be 15 321 (14 124-16 743) fewer deaths in people with HIV in western Europe. Interpretation Non-AIDS-related deaths are projected to increase over time due to the ageing population of people with HIV offsetting the AIDS-related mortality reduction. Efforts are needed to promote comprehensive care for the ageing HIV population and focus on the health needs of people with HIV across their lifespan. Funding US National Institute on Alcohol Abuse and Alcoholism and US National Institute of Allergy and Infectious Diseases. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Filiaciones:
Ambia, J:
Univ Bristol, Populat Hlth Sci, Bristol BS8 2BN, England
van Sighem, A:
Stichting HIV Monitoring, Amsterdam, Netherlands
Amsterdam Inst Immunol & Infect Dis, Amsterdam, Netherlands
Pantazis, N:
Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
Gill, MJ:
Univ Calgary, Dept Med, Calgary, AB, Canada
Grabar, S:
Sorbonne Univ, Hop St Antoine, AP HP,INSERM, Dept Sante Publ,Inst Pierre Louis Epidemiol & Sant, Paris, France
Monforte, AD:
Univ Milan, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy
Zangerle, R:
Med Univ Innsbruck, Dept Dermatol Venereol & Allergy, Innsbruck, Austria
:
Ctr Epidemiol Studies Sexually Transmitted Infect, Badalona, Spain
Teira, R:
Hosp Univ Sierrallana, Serv Med Interna, Cantabria, Spain
Jarrin, I:
Carlos III Hlth Inst, Natl Ctr Epidemiol, Madrid, Spain
Carlos III Hlth Inst, CIBER Enfermedades Infecciosas, Madrid, Spain
Vehreschild, J:
Univ Cologne, Fac Med, Dept Internal Med 1, Cologne, Germany
Univ Cologne, Univ Hosp Cologne, Cologne, Germany
Goethe Univ Frankfurt, Inst Digital Med & Clin Data Sci, Frankfurt, Germany
Cavassini, M:
Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland
Univ Lausanne, Lausanne, Switzerland
van der Valk, M:
Stichting HIV Monitoring, Amsterdam, Netherlands
Amsterdam Inst Immunol & Infect Dis, Amsterdam, Netherlands
Univ Amsterdam, Med Ctr, Amsterdam Inst Immunol & Infect Dis, Dept Infect Dis, Amsterdam, Netherlands
Bonnet, F:
CHU Bordeaux, Bordeaux, France
Univ Bordeaux, INSERM, Bordeaux Populat Hlth, U1219, Bordeaux, France
Sterne, JAC:
Univ Bristol, Populat Hlth Sci, Bristol BS8 2BN, England
Trickey, A:
Univ Bristol, Populat Hlth Sci, Bristol BS8 2BN, England
Green Submitted, Green Published, hybrid
|